Trade Gilead ^GILD

Correction to Gilead Sciences Veklury Sales Guidance Headline on Feb. 11 | Morningstar

Gilead (GILD) Upgraded to Overweight Amid Positive Outlook for HIV Franchise Growth | AAPL ...

Is Gilead Sciences (GILD) a Cheap NASDAQ Stock to Buy According to Hedge Funds?

Gilead Sciences (GILD) Upgraded by Cantor Fitzgerald with Positive Outlook | GILD Stock News

10,000 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Silverarc Capital Management LLC

J. Safra Sarasin Holding AG Sells 20,537 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Van Lanschot Kempen Investment Management N.V.

Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response

Gilead Sciences to propel healthcare innovation and cell therapy advancement in Abu Dhabi

Gilead Sciences (GILD) Reports Positive Phase 3 Results for Breast Cancer Treatment | GILD ...

Gilead Sciences (GILD) Surprises with Positive ASCENT-04 Results, Analyst Optimistic | GILD ...

Gilead's (GILD) Trodelvy Shows Promise in Breast Cancer Study

Gilead Sciences Sees Positive Results in Phase 3 Study of Aggressive Breast Cancer | Morningstar

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significan

MetLife Investment Management LLC Buys 6,109 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Curi RMB Capital LLC Has $7.81 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Reports Positive Data From Phase 3 ASCENT-04/KEYNOTE-D19 Study

4,185 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Gabelli Funds LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Position Reduced by Jump Financial LLC

Analysts' Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) | Markets Insider

Natixis Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by BI Asset Management Fondsmaeglerselskab A S

Capital International Inc. CA Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital World Investors

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dimensional Fund Advisors LP

Gilead Sciences Inc. Purchases New Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)

2,008,338 Shares in Ikena Oncology, Inc. (NASDAQ:IKNA) Purchased by Gilead Sciences Inc.

16,707,477 Shares in Galapagos NV (NASDAQ:GLPG) Bought by Gilead Sciences Inc.

Gilead Sciences Inc. Invests $19.03 Million in Merus (NASDAQ:MRUS)

6,720,803 Shares in Arcellx, Inc. (NASDAQ:ACLX) Bought by Gilead Sciences Inc.

Gilead Sciences Inc. Acquires New Position in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)

231,663 Shares in Agenus Inc. (NASDAQ:AGEN) Acquired by Gilead Sciences Inc.

Gilead Sciences Inc. Acquires Shares of 4,854,443 Tango Therapeutics, Inc. (NASDAQ:TNGX)

2,209,471 Shares in Assembly Biosciences, Inc. (NASDAQ:ASMB) Acquired by Gilead Sciences Inc.

Edgar Lomax Co. VA Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Forum Financial Management LP

Freedom Investment Management Inc. Sells 2,713 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Capital International Ltd. CA Sells 18,042 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Cadence Bank Sells 114,867 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital International Sarl

Capital Research Global Investors Has $5.35 Billion Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Natixis Has $24.96 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Norinchukin Bank The Grows Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Belmont Capital LLC Has $869,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Capital Group Investment Management PTE. LTD.

NewEdge Advisors LLC Increases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lessened by Insigneo Advisory Services LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Analysts

Arvest Bank Trust Division Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc. Invests $447.61 Million in Arcus Biosciences, Inc. (NYSE:RCUS)

Gilead Sciences Inc. Invests $461.73 Million in Galapagos NV (NASDAQ:GLPG)

CANADA LIFE ASSURANCE Co Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc. Buys Shares of 1,156,689 Allogene Therapeutics, Inc. (NASDAQ:ALLO)

5,319,148 Shares in Leap Therapeutics, Inc. (NASDAQ:LPTX) Purchased by Gilead Sciences Inc.

Canada Pension Plan Investment Board Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Marshall Wace LLP Has $112.40 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 2,500 Shares of Stock

Zacks Investment Management Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader ...

United Capital Financial Advisors LLC Decreases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Biomedical HIV Prevention Summit in Atlanta Is the Focus To Drive Meaningful Action With Gilead Sciences

Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dodge & Cox

Guggenheim Capital LLC Sells 34,237 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Belpointe Asset Management LLC Buys 4,433 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Synovus Financial Corp Trims Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) Advances Oncology Care Through Research Scholars Program | GILD ...

Gilead Sciences: Advancing Oncology Care Through Gilead's Research Scholars Program

Canada Post Corp Registered Pension Plan Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Rossby Financial LCC Invests $232,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

CreativeOne Wealth LLC Buys 9,105 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Mariner LLC

Gilead Sciences (NASDAQ:GILD) Shares Acquired Rep. Jefferson Shreve

Rep. Josh Gottheimer Buys Gilead Sciences, Inc. (NASDAQ:GILD) Shares

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)

Stamos Capital Partners L.P. Sells 19,510 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Sterling Capital Management LLC Purchases 42,040 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Sagespring Wealth Partners LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

FIL Ltd Sells 28,386 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Petros Family Wealth LLC Makes New $271,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Legacy Financial Advisors Inc. Takes $295,000 Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Trexquant Investment LP Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Heritage Trust Co Buys Shares of 40,679 Gilead Sciences, Inc. (NASDAQ:GILD)

Scotia Capital Inc. Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Bessemer Group Inc. Has $8.97 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

LSV Asset Management Sells 259,370 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Cerity Partners LLC Has $15.43 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) to Announce Q1 2025 Financial Results | GILD stock news

Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025 | ...

Gilead Sciences Inc (GILD) Shares Gap Down to $100.87 on Apr 10

Gilead Sciences Inc (GILD) Recognized for Excellence in ESG by Patient Advocacy Groups

Gilead Sciences (NASDAQ:GILD) Shares Gap Down - What's Next?

NORTHAMPTON, MA / ACCESS Newswire / April 10, 2025 / At Gile

PatientView Ranks Gilead "Best" at ESG